8-K: QT Imaging Holdings Enters Into Data Use and Services Agreements with QT Imaging Center
Material Agreement Announcement
QT Imaging Holdings has established agreements with QT Imaging Center for data licensing and healthcare services, including clinical trial support and training.
Summary
- QT Imaging Holdings, Inc. has entered into a Data Use and License Agreement with QT Imaging Center, a sole proprietorship of Dr. John Klock, a board member, to use de-identified health information for research and development.
- The company also entered into a Services Agreement with QT Imaging Center, where Dr. Klock will provide healthcare services, assist with clinical trials, and provide training on breast imaging technology.
- Dr. Klock will be compensated at $450 per hour for a minimum of 15 hours per week, not exceeding 60 hours per month, unless otherwise agreed upon.
- The Services Agreement has a one-year term with automatic renewal, subject to a review on July 1, 2024.
- QT Imaging Center will provide quarterly reports detailing services rendered, and QT Imaging Holdings will make payments within 15 business days of receiving the report.
Sentiment
Score: 7
Explanation: The agreements are positive for the company, providing access to data and expertise, but there are some risks associated with the related party transaction and reliance on a single individual.
Positives
- The agreements provide QT Imaging Holdings with access to valuable de-identified health data for research and development.
- The company secures expert services from Dr. Klock, including clinical trial support and training on their breast imaging technology.
- The data use license is perpetual, non-exclusive, royalty-free, and worldwide, allowing for broad use of the data.
- The agreements include provisions for fair market value compensation and compliance with healthcare laws.
Negatives
- The Services Agreement involves a related party transaction with a board member, which could raise conflict of interest concerns.
- The hourly rate of $450 for Dr. Klock's services may be considered high, although it is stated to be fair market value.
- The company is reliant on a single individual for key services, which could pose a risk if Dr. Klock is unavailable.
Risks
- The reliance on a related party for key services could lead to potential conflicts of interest.
- The cost of services from Dr. Klock could be significant if the company requires the maximum 60 hours per month.
- There is a risk of disputes over the Quarterly Reports, which could delay payments.
- The agreements are subject to review and possible revision on July 1, 2024, which could lead to changes in terms.
Future Outlook
The Services Agreement will be reviewed on July 1, 2024, and may be revised if the terms are not satisfactory to either party. The Data Use and License Agreement is perpetual, allowing for ongoing use of the data.
Management Comments
- The parties have agreed that the compensation is the fair market value for the professional time of Dr. Klock, without taking into consideration the volume of value of any referrals of business between the parties.
Industry Context
This announcement reflects a trend in the medical device industry where companies collaborate with medical professionals and centers to gain access to clinical data and expertise for product development and validation. The agreements also highlight the importance of data privacy and compliance with regulations like HIPAA and CCPA.
Comparison to Industry Standards
- The use of de-identified patient data for research and development is a common practice in the medical device industry, with companies like Medtronic and Abbott also engaging in similar data-sharing agreements.
- The hourly rate of $450 for a medical professional's services is within the range of what is typically charged for specialized consulting in the healthcare sector, comparable to rates charged by consultants at companies like McKinsey or Boston Consulting Group.
- The structure of the Services Agreement, with a one-year term and automatic renewal, is standard for consulting agreements in the industry, similar to contracts used by companies like Philips and Siemens with their clinical partners.
- The data use license being perpetual, non-exclusive, royalty-free, and worldwide is a common approach for companies seeking to maximize the value of data for research and development, similar to data licenses used by companies like GE Healthcare.
Related Party Transactions
- The Services Agreement and Data Use and License Agreement are with QT Imaging Center, a sole proprietorship of Dr. John Klock, a member of the company's board of directors.
Stakeholder Impact
- Shareholders may view the agreements positively as they provide access to valuable resources for product development.
- Employees may benefit from the expertise and training provided by Dr. Klock.
- Customers may benefit from improved products and services resulting from the research and development efforts.
- Suppliers may see increased business opportunities as the company expands its operations.
Next Steps
- QT Imaging Center will begin providing services to QT Imaging Holdings as outlined in the Services Agreement.
- QT Imaging Holdings will begin using the licensed de-identified health data for research and development.
- The parties will review the Services Agreement on July 1, 2024, and may revise the terms.
- QT Imaging Center will provide quarterly reports on services rendered, and QT Imaging Holdings will make payments accordingly.
Key Dates
| Date | Description |
|---|---|
| 2024-04-01 | Effective date of the Services Agreement. |
| 2024-04-03 | Date of the Data Use and License Agreement and the Services Agreement. |
| 2024-04-05 | Date the Services Agreement was entered into. |
| 2024-07-01 | Date for review and possible revision of the Services Agreement. |
| 2024-04-08 | Date of the 8-K filing. |
Keywords
Data Use Agreement, Services Agreement, De-identified Health Information, Clinical Trials, Breast Imaging, Medical Device, Healthcare Services, Training, Research and Development, Related Party Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.